StockData
Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) stock

MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.28−0.12 (-1.62%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Maravai LifeSciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Maravai LifeSciences's EV/EBITDA was 14.9× on Jan 31, 2024, against 5.7× a year earlier. Over the last 2 years it ranged from 5.6× to 367.8×, with a median of 9.2×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 202414.9×−1.4
2023Dec 29, 202316.3×+10.7
2022Dec 30, 20225.6×−362.2
2021Jan 29, 2021367.8×+71.9
2020Dec 31, 2020295.9×–

More Maravai LifeSciences figures

See a number that looks wrong?